Transfusion in paediatrics requires specific guidelines, because child physiology and
pathology differ significantly as compared to adults. Adverse transfusion reactions in …

The development of hemolytic erythrocyte alloantibodies and autoantibodies complicates
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …

Objective The development of red blood cell alloimmunization intensifies transfusion
complication in thalassaemia patients. The purpose of this paper is to evaluate the existing …

Objectives HLA alloimmunization is one of the most troublesome consequence of regular
transfusion which is itself a mainstay measure to provide longevity to the thalassemia …

We here report the first study of antigen and phenotype frequencies of Rh (C, c, E, e), M, Mia
and Kidd antigens in north‐east Thai blood donors. Blood transfusion services aim to ensure …

Background Alloimmunization prevalence is conventionally used to identify RBCs
alloimmunization risk factors among thalassemia patients, but it may be confounded by …

BACKGROUND Children with transfusion dependent anemia, such as sickle cell disease
(SCD) and thalassemia, are at an increased risk for developing red blood cell (RBC) …

Red cell alloimmunization is associated with increased health care costs, longer
hospitalizations, and higher mortality | Blood Advances | American Society of Hematology Skip …

Autoimmune hemolytic anemia (AIHA) is characterized by hemolysis caused by
autoantibodies. However, many patients do not respond to therapies and may have an …

Background Thalassemia is a common genetic disease in Southeast Asia. Red blood cell
(RBC) transfusion is an essential treatment for severe forms of thalassemia. We performed a …